Methods and formulations of using A1 adenosine and P2X purinoreceptor antagonists

• 1. 用作腺苷A1受体拮抗剂的黄嘌呤衍生物 [P] . 中国专利： CN1118599A . 1996-03-13
• 2. 作为A2B腺苷受体拮抗剂的前药的嘌呤化合物、它们的制备方法及医药用途 [P] . 中国专利： CN103261200B . 2016.03.30
• 3. METHODS AND FORMULATIONS OF USING A1 ADENOSINE AND P2X PURINORECEPTOR ANTAGONISTS [P] . 欧洲知识产权局专利： EP1390068A4 . 2006-04-05

  机译： 使用A1腺苷和P2X普鲁诺受体拮抗剂的方法和剂型

• 4. METHODS AND FORMULATIONS OF USING A1 ADENOSINE AND P2X PURINORECEPTOR ANTAGONISTS [P] . 欧洲知识产权局专利： EP1390068A1 . 2004-02-25

  机译： 使用A1腺苷和P2X普鲁诺受体拮抗剂的方法和剂型

• 5. METHODS AND FORMULATIONS OF USING A1 ADENOSINE AND P2X PURINORECEPTOR ANTAGONISTS [P] . 世界知识产权组织专利： WO02094317A1 . 2002-11-28

  机译： 使用A1腺苷和P2X普鲁诺受体拮抗剂的方法和剂型

• 1. The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer’s disease：agonists or antagonists? [J] . Rubina Marzagalli, Alessandro Castorina 中国神经再生研究（英文版） . 2015,第002期
• 2. Insights into binding modes of adenosine A2B antagonists with ligand-based and receptor-based methods [C] . Feixiong Cheng, Zhejun Xu, Guixia Liu, ICMSI;International conference of molecular simulations and applied informatics technologies . 2010
• 3. The Modulatory Role of Caffeine and Other Adenosine Receptor Antagonists onto Spinal Locomotor Circuits: Evidence for its Dependence on Adenosine A1- Dopamine D1 Receptor Heteromers in Spinal Motoneurons. [D] . Rivera-Oliver, Marla. 2017
• 4. Sex Differences in the Neurotoxic Effects of Adenosine A1 Receptor Antagonism During Ethanol Withdrawal: Reversal With an A1 Receptor Agonist or an NMDA Receptor Antagonist [O] . Tracy R. Butler, Katherine J. Smith, Rachel L. Self, -1
• 5. Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) [O] . Voors Adriaan A., Dittrich Howard C., Massie Barry M., 2011

• 1. Pretreatment with adenosine and adenosine A1 receptor agonist protects against intestinal ischemia-reperfusion injury in rat [J] . V Haktan Ozacmak ,Hale Sayan . 世界胃肠病学杂志：英文版 . 2007,第4期
• 2. Motor Effects of 1,3-Disubstituted 8-Styrylxanthines as A_(1) and A_(2) Adenosine-Receptor Antagonists in Rats [J] . Ilhuicamina Daniel Limon-Perez de Leon ,Maria del Carmen Parra-Cid ,Alejandro Munoz-Zurita . 药理与制药（英文） . 2013,第3期
• 3. Effect of Adenosine A2A Receptor Antagonist ZM241385 on Amygdala-kindled Seizures and Progression of Amygdala Kindling [J] . Xiang LI ,Huicong KANG ,Xiaoyan LIU . 华中科技大学学报（医学）（英德文版） . 2012,第002期
• 4. Electronic Structure of some A3 Adenosine-Receptor Antagonist——A Structure Activity Relationship [J] . Rifaat Hilal ,M. F Shibl ,Moteaa El-Deftar . 量子信息科学期刊（英文） . 2011,第1期
• 5. 激活三磷酸腺苷P2x受体引起感宽神经突触释放神经递质谷氨酸 [C] . . 中国科协第三届青年学术年会 . 1998
• 6. 腺苷A1和A2A受体拮抗剂对睡眠剥夺大鼠不同脑区ERK1/2和pERK1/2的影响 [A] . 李玲 . 2011